Sex differences in ICDs for primary prevention: Time to include women in ICD trials!
作者信息
Ciuffo Luisa Allen, Redberg Rita F
机构信息
UCSF School of Medicine, Division of Cardiology, United States of America.
出版信息
Am Heart J Plus. 2022 May 4;16:100141. doi: 10.1016/j.ahjo.2022.100141. eCollection 2022 Apr.
Abstract
摘要
相似文献
1
Sex differences in ICDs for primary prevention: Time to include women in ICD trials!原发性预防中植入式心律转复除颤器的性别差异：是时候让女性参与植入式心律转复除颤器试验了！
Am Heart J Plus. 2022 May 4;16:100141. doi: 10.1016/j.ahjo.2022.100141. eCollection 2022 Apr.
2
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用：基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
3
Subcutaneous versus transvenous implantable cardioverter defibrillator in hypertrophic cardiomyopathy: a systematic review and meta-analysis.肥厚型心肌病患者皮下与经静脉植入式心律转复除颤器的比较：一项系统评价和荟萃分析。
Cardiovasc Diagn Ther. 2024 Jun 30;14(3):318-327. doi: 10.21037/cdt-24-15. Epub 2024 Jun 27.
4
Safety and Efficacy of an Implantable Cardioverter Defibrillator (ICD) in the Detection and Prevention of Cardiac Arrhythmia - A Systematic Review.植入式心脏复律除颤器（ICD）在检测和预防心律失常中的安全性和有效性——一项系统评价
Cureus. 2023 Nov 7;15(11):e48471. doi: 10.7759/cureus.48471. eCollection 2023 Nov.
5
A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance.与植入式心脏复律除颤器接受度相关的患者相关因素的定性分析
Cardiol Ther. 2020 Dec;9(2):421-432. doi: 10.1007/s40119-020-00180-9. Epub 2020 May 31.
6
Primary prevention implantable cardioverter-defibrillators and survival in older women.老年女性的一级预防植入式心脏复律除颤器与生存率
JACC Heart Fail. 2015 Feb;3(2):159-67. doi: 10.1016/j.jchf.2014.09.006. Epub 2014 Nov 5.
7
Decision-making regarding subcutaneous implantable cardioverter defibrillator as primary prevention in patients with low ejection fraction.关于低射血分数患者皮下植入式心律转复除颤器作为一级预防的决策。
Pacing Clin Electrophysiol. 2024 Oct;47(10):1285-1292. doi: 10.1111/pace.15065. Epub 2024 Aug 19.
8
Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.适当的植入式心脏复律除颤器治疗在二级预防患者中的死亡率影响：前瞻性基于人群的登记处中一级预防患者死亡率的对比。
J Am Heart Assoc. 2017 Aug 19;6(8):e006220. doi: 10.1161/JAHA.117.006220.
10
Sex Differences in Outcomes of Patients with an Implantable Cardioverter-Defibrillator for the Secondary Prevention of Sudden Cardiac Death.植入式心脏复律除颤器用于心脏性猝死二级预防患者的预后性别差异
J Cardiovasc Dev Dis. 2024 Apr 5;11(4):116. doi: 10.3390/jcdd11040116.
引用本文的文献
1
Special issue: Women and cardiovascular trials.特刊：女性与心血管试验。
Am Heart J Plus. 2024 Jul 25;45:100427. doi: 10.1016/j.ahjo.2024.100427. eCollection 2024 Sep.
本文引用的文献
1
Underrepresentation of women in implantable cardioverter defibrillator trials.植入式心脏复律除颤器试验中女性参与者人数不足。
Am Heart J Plus. 2022 Mar 29;14:100120. doi: 10.1016/j.ahjo.2022.100120. eCollection 2022 Feb.
2
Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017.2010 年至 2017 年女性参与心血管临床试验情况。
Circulation. 2020 Feb 18;141(7):540-548. doi: 10.1161/CIRCULATIONAHA.119.043594. Epub 2020 Feb 17.
3
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会报告
Heart Rhythm. 2018 Oct;15(10):e190-e252. doi: 10.1016/j.hrthm.2017.10.035. Epub 2017 Oct 30.
4
Do women benefit equally as men from the primary prevention implantable cardioverter-defibrillator?女性是否能像男性一样从初级预防植入式心脏除颤器中同等受益？
Europace. 2018 Jun 1;20(6):897-901. doi: 10.1093/europace/eux203.
5
Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.心力衰竭患者在心脏再同步治疗中加用除颤器的性别特异性结局。
Heart. 2017 May;103(10):753-760. doi: 10.1136/heartjnl-2016-310677. Epub 2017 Jan 19.
6
Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).一级预防植入式心脏复律除颤器植入后的性别与预后：来自国家心血管数据注册库（NCDR）的研究结果
Am Heart J. 2015 Aug;170(2):330-8. doi: 10.1016/j.ahj.2015.02.025. Epub 2015 Apr 23.
7
Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.心脏再同步治疗中左心室射血分数的正常化与室性心律失常和临床结局的风险：来自多中心自动除颤器植入试验与心脏再同步治疗（MADIT-CRT）试验的结果。
Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9.
8
Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.心脏再同步治疗在女性中的应用：美国食品和药物管理局患者水平数据的荟萃分析。
JAMA Intern Med. 2014 Aug;174(8):1340-8. doi: 10.1001/jamainternmed.2014.2717.
9
Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.性别对植入式心脏复律除颤器治疗效果的影响：来自前瞻性除颤器数据库的发现。
Ann Intern Med. 2012 Feb 7;156(3):195-203. doi: 10.7326/0003-4819-156-3-201202070-00007.
10
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.心脏再同步治疗在女性中的疗效优于男性：MADIT-CRT（心脏再同步治疗的多中心自动除颤器植入试验）试验。
J Am Coll Cardiol. 2011 Feb 15;57(7):813-20. doi: 10.1016/j.jacc.2010.06.061.
Zotero 插件